13F

Stock

Supernus Pharmaceuticals, Inc.

SUPN · held by 5 managers

Reported value

$5.39M

Holders

5

+0 new · −1 exited

Holders’ est. mark

−$160.1K

Price effect on 4 books still in the name

Largest holder

$4.44M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC140.9K$4.44M−$123KAdded$1.17M
Henshaw Capital LLC21.1K$663.6K−$25.9KCut−$25.9K
FIRST NATIONAL BANK OF OMAHA8.96K$282.6K−$11KCut−$18.5K
DANSKE BANK A/S100$3.15K−$123Cut−$123
Essential Partners LLC61$1.92KHeld

Who left

Positions as of Q2 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.